![First HIV Vaccine that Also Serves as Twice Yearly ARV Coming To Kenya Soon](https://habarikenya.sokofind.com/wp-content/uploads/2024/10/HIV-Vaccine-kenya-600x400.jpg)
First HIV Vaccine that Also Serves as Twice Yearly ARV Coming To Kenya Soon
Kenya stands on the brink of a revolutionary advancement in HIV prevention and treatment, as Gilead Sciences’ groundbreaking drug lenacapavir moves closer to widespread availability. This innovative medication, which can be administered as an injection just twice a year, promises to serve both as a preventive vaccine and an antiretroviral (ARV) treatment, offering new hope…